lifestyle.capitolhilltimes.com

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • Nourish Launches Free Labs Offering, Integrating Blood Testing Into Personalized Nutrition Care

    Nourish Launches Free Labs Offering, Integrating Blood Testing Into Personalized Nutrition Care

    Business Wire
    January 30, 2026
  • Forecast: US white-collar and tech jobs may strengthen in Q1 2026

    Forecast: US white-collar and tech jobs may strengthen in Q1 2026

    Matthew Campbell-Miller for Toptal
    January 30, 2026
  • Stop doing everything: How small business leaders can reclaim 77 workdays each year

    Stop doing everything: How small business leaders can reclaim 77 workdays each year

    Beth Kempton for Upwork
    January 30, 2026
  • How to reduce senior care overtime costs with optimized nurse scheduling

    How to reduce senior care overtime costs with optimized nurse scheduling

    Matt Durgin for SmartLinx
    January 30, 2026
  • A guide to off-road electric vehicles

    A guide to off-road electric vehicles

    Brendan Soriano for RealTruck.Com
    January 30, 2026
  • Nexus Renewables Announces New Board Appointment and Leadership Transition

    Nexus Renewables Announces New Board Appointment and Leadership Transition

    Boykin, Sam
    January 30, 2026
  • Russian Sandworm group attacks energy company in Poland with DynoWiper, ESET Research discovers

    Russian Sandworm group attacks energy company in Poland with DynoWiper, ESET Research discovers

    ESET
    January 30, 2026
  • Rio2 Completes Acquisition of the Condestable Mine

    Rio2 Completes Acquisition of the Condestable Mine

    Rio2 Limited
    January 30, 2026
  • Ovide Mercredi Appointed to Arctic Gateway Group Board of Directors

    Ovide Mercredi Appointed to Arctic Gateway Group Board of Directors

    Arctic Gateway Group
    January 30, 2026
  • Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma

    Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma

    Elevar Therapeutics
    January 30, 2026
Prev
1 … 11,044 11,045 11,046 11,047 11,048 … 30,769
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.